Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

30 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Galectin-3 is elevated in CSF and is associated with Aβ deposits and tau aggregates in brain tissue in Alzheimer's disease.
Boza-Serrano A, Vrillon A, Minta K, Paulus A, Camprubí-Ferrer L, Garcia M, Andreasson U, Antonell A, Wennström M, Gouras G, Dumurgier J, Cognat E, Molina-Porcel L, Balasa M, Vitorica J, Sánchez-Valle R, Paquet C, Venero JL, Blennow K, Deierborg T. Boza-Serrano A, et al. Among authors: vrillon a. Acta Neuropathol. 2022 Nov;144(5):843-859. doi: 10.1007/s00401-022-02469-6. Epub 2022 Jul 27. Acta Neuropathol. 2022. PMID: 35895141 Free PMC article.
Head-to-head comparison of clinical performance of CSF phospho-tau T181 and T217 biomarkers for Alzheimer's disease diagnosis.
Karikari TK, Emeršič A, Vrillon A, Lantero-Rodriguez J, Ashton NJ, Kramberger MG, Dumurgier J, Hourregue C, Čučnik S, Brinkmalm G, Rot U, Zetterberg H, Paquet C, Blennow K. Karikari TK, et al. Among authors: vrillon a. Alzheimers Dement. 2021 May;17(5):755-767. doi: 10.1002/alz.12236. Epub 2020 Nov 30. Alzheimers Dement. 2021. PMID: 33252199 Free PMC article.
COVID-19 in adults with dementia: clinical features and risk factors of mortality-a clinical cohort study on 125 patients.
Vrillon A, Mhanna E, Aveneau C, Lebozec M, Grosset L, Nankam D, Albuquerque F, Razou Feroldi R, Maakaroun B, Pissareva I, Cherni Gherissi D, Azuar J, François V, Hourrègue C, Dumurgier J, Volpe-Gillot L, Paquet C. Vrillon A, et al. Alzheimers Res Ther. 2021 Apr 10;13(1):77. doi: 10.1186/s13195-021-00820-9. Alzheimers Res Ther. 2021. PMID: 33838684 Free PMC article.
Amyloid pathology and synaptic loss in pathological aging.
Gkanatsiou E, Nilsson J, Toomey CE, Vrillon A, Kvartsberg H, Portelius E, Zetterberg H, Blennow K, Brinkmalm A, Lashley T, Brinkmalm G. Gkanatsiou E, et al. Among authors: vrillon a. J Neurochem. 2021 Oct;159(2):258-272. doi: 10.1111/jnc.15487. Epub 2021 Sep 2. J Neurochem. 2021. PMID: 34473357 Free article.
Differences Between Plasma and Cerebrospinal Fluid Glial Fibrillary Acidic Protein Levels Across the Alzheimer Disease Continuum.
Benedet AL, Milà-Alomà M, Vrillon A, Ashton NJ, Pascoal TA, Lussier F, Karikari TK, Hourregue C, Cognat E, Dumurgier J, Stevenson J, Rahmouni N, Pallen V, Poltronetti NM, Salvadó G, Shekari M, Operto G, Gispert JD, Minguillon C, Fauria K, Kollmorgen G, Suridjan I, Zimmer ER, Zetterberg H, Molinuevo JL, Paquet C, Rosa-Neto P, Blennow K, Suárez-Calvet M; Translational Biomarkers in Aging and Dementia (TRIAD) study, Alzheimer’s and Families (ALFA) study, and BioCogBank Paris Lariboisière cohort. Benedet AL, et al. Among authors: vrillon a. JAMA Neurol. 2021 Dec 1;78(12):1471-1483. doi: 10.1001/jamaneurol.2021.3671. JAMA Neurol. 2021. PMID: 34661615 Free PMC article.
P-tau235: a novel biomarker for staging preclinical Alzheimer's disease.
Lantero-Rodriguez J, Snellman A, Benedet AL, Milà-Alomà M, Camporesi E, Montoliu-Gaya L, Ashton NJ, Vrillon A, Karikari TK, Gispert JD, Salvadó G, Shekari M, Toomey CE, Lashley TL, Zetterberg H, Suárez-Calvet M, Brinkmalm G, Rosa Neto P, Blennow K. Lantero-Rodriguez J, et al. Among authors: vrillon a. EMBO Mol Med. 2021 Dec 7;13(12):e15098. doi: 10.15252/emmm.202115098. Epub 2021 Nov 2. EMBO Mol Med. 2021. PMID: 34725927 Free PMC article.
Association of Plasma p-tau181 and p-tau231 Concentrations With Cognitive Decline in Patients With Probable Dementia With Lewy Bodies.
Gonzalez MC, Ashton NJ, Gomes BF, Tovar-Rios DA, Blanc F, Karikari TK, Mollenhauer B, Pilotto A, Lemstra A, Paquet C, Abdelnour C, Kramberger MG, Bonanni L, Vandenberghe R, Hye A, Blennow K, Zetterberg H, Aarsland D; European–Dementia With Lewy Bodies (E-DLB) Consortium. Gonzalez MC, et al. JAMA Neurol. 2022 Jan 1;79(1):32-37. doi: 10.1001/jamaneurol.2021.4222. JAMA Neurol. 2022. PMID: 34807233 Free PMC article.
30 results